USPTO serial 75176361
SILANES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 27, 1999
- Examiner
- POWERS, ALEXANDER L
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with SILANES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
LABORATORIOS SILANES, S.A. DE C.V.
Ciudad de México, MX
Other trademarks owned by LABORATORIOS SILANES, S.A. DE C.V.
LABORATORIOS SILANES, S.A. DE C.V.
Mexico City, MX
Other trademarks owned by LABORATORIOS SILANES, S.A. DE C.V.
LABORATORIOS SILANES, S.A. DE C.V.
Mexico City, MX
Other trademarks owned by LABORATORIOS SILANES, S.A. DE C.V.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jason L DeFrancesco
Jason L DeFrancesco DeFrancesco Lee LLC174 Nassau St, No 342Princeton, NJ 08542UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceuticals, namely, injectable solutions, tablets, pills and capsules for adults and children, oral suspension, medicated syrup and ointment, all for treatment as a cough suppressant, and expectorant, [ activity against anaerobic bacteria, Trichomona vaginalis, Entamoeba histolytica, and giardia lamblia, ] as an antifungal agent for treatment of Oropharyngeal and esophageal candidiasis, [ candidial urinary tract infections, peritonitis and systemic candidal infections, candidemia, disseminated candidiasis and pneumonia, cryptococcal meningitis, candidal genital tract infections, ] as an analgesis anti-inflamatory non steroidal inhibitor of prostaglandin synthetase, [ analgesic and minor tranquilizer, active immunization against tetanus, peripheral neuritis, neuralgias, peripheral neuritis, neuralgias and haematopoietic, antifungal agent for treatment of systemic blastomycosis, histoplasmosis paracoccidloidomycosis, fungal infection of the gastrointestinal tract and tinea infections of the skin, and nails, sulphonylurea and biguanide, hipoglycaemic agent, activity against trichomonas vaginalis, entamoeba histolytica and Giardia lamblia, anaerobic bacteria, ] histamine H1-receptor antagonist and prophylactic treatment of asthma, and treatment of allergic conditions such as rhinitis and conjuntivitis,[ analgesic, ] anti-inflamatory non steroidal, for inhibiting prostaglanding synthetase, [ analgesic, anti-inflammatory non steroidal, inhibitor of prostaglandin synthetase ] and muscle relaxant, analgesic, antipyretic, [ sulphonylurea hipoglycaemic agent, for inhibiting as an angiotensin-converting enzyme, treatment of congestive heart failure and asymptomatic left ventricular dysfunction, diuretic treatment of congestive heart failure, hypertension, cardiac, renal hepatogenic oedema, peripheral neuritis, neuralgias and analgesic, ] a broad spectrum antibiotic, effective against a wide range of Gram positive and Gram negative aerobic and anaerobic bacterias, [ histamin H2-receptor antagonist in the treatment of gastric an duodenal ulcer, Zollinger-Ellison syndrome, iron deficiency and anemia for children or adults, ] anixolytic, anticonvulsant, sedative, muscle relaxant, [ histamine H2-receptor antagonist in the treatment of gastric and duodenal ulcer Zollinger-Ellison syndrome, ] multivitamin treatment and prevention of vitamin B1-B6-B12 deficiency, [ tricyclic antidepressant, treatment of nocturnal enuresis in children, inhibits angiotensin-converting enzyme, ] treatment of hypertension and congestive heart failure, treatment and prevention of vitamic C deficiency, treatment and prevention of seborrhoea and dandruff, analgesic no narcotic | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LABORATORIOS SILANES, S.A. DE C.V.
- Other trademarks owned by LABORATORIOS SILANES, S.A. DE C.V.
- Other trademarks owned by LABORATORIOS SILANES, S.A. DE C.V.
- Other trademarks in Class 005
- Similar marks named SILANES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 23, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 23, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 23, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 16, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 16, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 21, 2019 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| May 21, 2019 | RNL2 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| May 21, 2019 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| May 20, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 16, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 16, 2019 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Apr 27, 2018 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Feb 26, 2009 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Feb 26, 2009 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Feb 19, 2009 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Jul 13, 2007 | CFIT | CASE FILE IN TICRS | — |
| Dec 30, 2005 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Oct 27, 2005 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Oct 27, 2005 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Apr 27, 1999 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 15, 1999 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Dec 15, 1998 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 29, 1998 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Sep 22, 1998 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 21, 1998 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 20, 1998 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 20, 1998 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jul 17, 1998 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jul 17, 1998 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jul 9, 1998 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 18, 1998 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 18, 1997 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 14, 1997 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 12, 1997 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 1997 | DOCK | ASSIGNED TO EXAMINER | — |